Allele 4G of gene PAI-1 associated with prothrombin mutation G20210A increases the risk for venous thrombosis

Thrombosis and Haemostasis

Volumn 90, Issue 6, 2003, Pages 1061-1064

  Barcellona, Doris ^a   Fenu, Lara ^a   Cauli, Cristiana ^a   Pisu, Giulia ^a   Marongiu, Francesco ^a  

^a UNIVERSITY OF CAGLIARI   (Italy)

Author keywords

4G 5G polymorphism of PAI 1 gene; Deep vein thrombosis; G20210A prothrombin mutation

Indexed keywords

ALANINE; GLYCINE; PLASMINOGEN ACTIVATOR INHIBITOR 1; PROTHROMBIN;

ADULT; AGED; ALLELE; ARTICLE; CEREBRAL SINUS THROMBOSIS; CONFIDENCE INTERVAL; CONTROLLED STUDY; DEEP VEIN THROMBOSIS; DISEASE PREDISPOSITION; FEMALE; GENE MUTATION; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENOTYPE; HETEROZYGOTE; HUMAN; LOGISTIC REGRESSION ANALYSIS; LUNG EMBOLISM; MAJOR CLINICAL STUDY; MALE; MESENTERIC VEIN THROMBOSIS; PORTAL VEIN THROMBOSIS; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR; VEIN THROMBOSIS; VENOUS THROMBOEMBOLISM;

EID: 0346903208     PISSN: 03406245     EISSN: None     Source Type: Journal    
DOI: 10.1160/th02-12-0305     Document Type: Article

References (18)

1. Ny T, Sawdey M, Lawrence D, et al. Cloning and sequence of a cDNA coding for the human beta-migrating-endothelial-cell-type plasminogen activator inhibitor. Proc Natl Acad Sci USA 1986; 83: 6776-80.
2. Dawson S, Wiman B, Hamsten A, et al. The two allele sequences of a common polymorphism in the promoter of the plasminogen activator inhibitor (PAI-1) gene respond differently to interleukin-1 in hepG2 cell. J Biol Chem 1993; 268: 10739-745.
3. Eriksson P, Kalling B, Van't Hooft FM, et al. Allele-specific increase in basal transcription of the plasminogen activator inhibitor 1 gene is associated with myocardial infarction. Proc Natl Acad Sci U S A 1995; 92: 1851-55.
4. Kohler HP, Grant PJ. Plasminogen-activator inhibitor type I and coronary artery disease. New Engl J Med 2000; 342: 1792-801
5. Hamsten A, Wiman B, De Faire U, Blomback M. Increased plasma levels of a rapid inhibitor of tissue plasminogen activator in young survivors of myocardial infarction. New Engl J Med 1985; 313: 1157-63
6. Mansfield MW, Stikland MH, Grant PJ. Plasminogen activator inhibitor-1 (PAI-1) promoter polymorphism and coronary artery disease in non-insulin-dependent diabetes. Thromb Haemost, 1995; 74: 1032-34.
7. Iacoviello L, Burzutta E, Di Castelnuovo A et al. The 4G/5G polymorphism of the PAI-1 promoter gene and the risk of myocardial infarction: A meta-analysis. Thromb Haemast 1998; 80: 1029-30.
8. Sartori MT, Wiman B, Vettore S, et al. 4G/5G polymorphism of PAI-1 gene promoter and fibrinolytic capacity in patients with deep vein thrombosis. Thromb Haemost 1998; 80: 956-60.
9. Stegnar M, Uhrin P, Peternel P, et al. The 4G/5G sequence polymorphism in the promoter of the plasminogen activator inhibitor-1 (PAI-1) gene: Relationship to PAI-1 level in venous thromboembolism. Thromb Haemost 1998; 79: 975-79.
10. Ridker MP, Hennekens CH, Lindpainter K, et al. Arterial and venous thrombosis is not associated with the 4G/5G polymorphism in the promoter of the plasminogen activator inhibitor gene in a large cohorte of US men. Circulation 1997; 95: 59-62.
11. Iglesias Varela ML, Adamczuk YP, et al. Major and potential prothrombotic genotype in a cohort of patients with venous thromboembolism. Thromb Res 2001; 104: 317-24.
12. Akar N, Yilmaz E, Akar E, et al. Effect of plasminogen activator inhibitor - 1 4G/5G polymorphism in Turkish deep vein thrombotic patients with and without FV 1691 G-A. Thromb Res 2000; 97: 227-30.
13. Visanji JM, Seargent J, Tahri D, et al. Influence of the -675 4G/5G dimorphism of the plasminogen activator inhibitor 1 promoter on thrombotic risk in patients with factor V Leiden. Br J Haematol 2000; 110: 135-38.
14. Zoller B, Garcia De Frutos P, Dahlback B. A common 4G allele in the promoter of the plasminogen activator inhibitor-1 (PAI-1) gene as a risk factor for pulmonary embolism and arterial thrombosis in hereditary protein S deficiency. Thromb Haemost 1998; 79: 802-7.
15. Martinelli I. Risk factor in venous thromboembolism. Thromb Haemost 2001; 86: 395-403.
16. Poort SR, Rosendaal FR, Reitsma PH, et al. A common genetic variation in the 3′ untranslated region of the prothrombin gene is associated with elevated plasma prothrombin levels and an increase venous thrombosis. Blood 1996; 88; 3698-703.
17. Falk G, Almqvist A, Nordenhem A, et al. Allele specific PCR for detection of a sequence polymorphism in the promoter region of the plasminogen activator inhibitor-1 (PAI-1) gene. Fibrinolysis 1995; 9: 170-74.
18. Segui R, Estelles A, Mira Y, et al. PAI-1 promoter 4G/5G genotype as an additional risk factor for venous thrombosis in subjects with genetic thrombophilic defects. Br J Haematol 2000; 111: 122-8.